Search research articles
Contact Us
Filters
Showing results (11-20 of 80) with videos related to
Page
of 8
Sort By:
Protein Expression and Purification
|
October 1, 1992
High-level expression and simplified purification of recombinant ricin A chain
B Y Li, A E Frankel, S Ramakrishnan
Seminars in Pediatric Surgery
|
August 1, 1996
Genetic engineering of immunotoxins
J C Chandler, A E Frankel, E P Tagge
Cancer Drug Delivery
|
January 1, 1987
Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma
A A Hertler, L E Spitler, A E Frankel
American Journal of Hematology
|
June 1, 1981
Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange
A E Frankel, M D Rubenstein, R T Wall
Cancer Biotherapy & Radiopharmaceuticals
|
January 13, 2001
Cell surface receptor-targeted therapy of acute myeloid leukemia: a review
A E Frankel, E L Sievers, D A Scheinberg
Seminars in Cancer Biology
|
October 1, 1995
Clinical trials of targeted toxins
A E Frankel, E P Tagge, M C Willingham
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1982
Human prostate specific and shared differentiation antigens defined by monoclonal antibodies
A E Frankel, R V Rouse, L A Herzenberg
American Journal of Hematology
|
May 20, 1998
DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma
M Duvic, J Cather, J Maize, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Targeted toxins
A E Frankel, R J Kreitman, E A Sausville
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 5, 2001
Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia
A E Frankel, M W Schuster, J G Jurcic
Page
of 8
Search research articles
Search
Showing results (11-20 of 80) with videos related to
Sort By:
Page
of 8
Protein Expression and Purification
|
October 1, 1992
High-level expression and simplified purification of recombinant ricin A chain
B Y Li, A E Frankel, S Ramakrishnan
Seminars in Pediatric Surgery
|
August 1, 1996
Genetic engineering of immunotoxins
J C Chandler, A E Frankel, E P Tagge
Cancer Drug Delivery
|
January 1, 1987
Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma
A A Hertler, L E Spitler, A E Frankel
American Journal of Hematology
|
June 1, 1981
Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange
A E Frankel, M D Rubenstein, R T Wall
Cancer Biotherapy & Radiopharmaceuticals
|
January 13, 2001
Cell surface receptor-targeted therapy of acute myeloid leukemia: a review
A E Frankel, E L Sievers, D A Scheinberg
Seminars in Cancer Biology
|
October 1, 1995
Clinical trials of targeted toxins
A E Frankel, E P Tagge, M C Willingham
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1982
Human prostate specific and shared differentiation antigens defined by monoclonal antibodies
A E Frankel, R V Rouse, L A Herzenberg
American Journal of Hematology
|
May 20, 1998
DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma
M Duvic, J Cather, J Maize, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Targeted toxins
A E Frankel, R J Kreitman, E A Sausville
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 5, 2001
Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia
A E Frankel, M W Schuster, J G Jurcic
Page
of 8